Aldeyra Therapeutics (ALDX) Competitors $4.76 -0.18 (-3.64%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ALDX vs. NATR, VSTM, VRCA, VYNE, NXTC, ANIP, MRVI, ARDX, AUPH, and OPKShould you be buying Aldeyra Therapeutics stock or one of its competitors? The main competitors of Aldeyra Therapeutics include Nature's Sunshine Products (NATR), Verastem (VSTM), Verrica Pharmaceuticals (VRCA), VYNE Therapeutics (VYNE), NextCure (NXTC), ANI Pharmaceuticals (ANIP), Maravai LifeSciences (MRVI), Ardelyx (ARDX), Aurinia Pharmaceuticals (AUPH), and OPKO Health (OPK). These companies are all part of the "pharmaceutical preparations" industry. Aldeyra Therapeutics vs. Nature's Sunshine Products Verastem Verrica Pharmaceuticals VYNE Therapeutics NextCure ANI Pharmaceuticals Maravai LifeSciences Ardelyx Aurinia Pharmaceuticals OPKO Health Nature's Sunshine Products (NASDAQ:NATR) and Aldeyra Therapeutics (NASDAQ:ALDX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking. Does the media refer more to NATR or ALDX? In the previous week, Aldeyra Therapeutics had 14 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 15 mentions for Aldeyra Therapeutics and 1 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.50 beat Aldeyra Therapeutics' score of 0.13 indicating that Nature's Sunshine Products is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nature's Sunshine Products 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Aldeyra Therapeutics 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings & valuation, NATR or ALDX? Nature's Sunshine Products has higher revenue and earnings than Aldeyra Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNature's Sunshine Products$445.32M0.66$15.08M$0.8818.18Aldeyra TherapeuticsN/AN/A-$37.54MN/AN/A Which has more risk and volatility, NATR or ALDX? Nature's Sunshine Products has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Aldeyra Therapeutics has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. Do insiders and institutionals believe in NATR or ALDX? 79.4% of Nature's Sunshine Products shares are owned by institutional investors. Comparatively, 59.7% of Aldeyra Therapeutics shares are owned by institutional investors. 4.9% of Nature's Sunshine Products shares are owned by company insiders. Comparatively, 8.5% of Aldeyra Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the MarketBeat Community favor NATR or ALDX? Aldeyra Therapeutics received 316 more outperform votes than Nature's Sunshine Products when rated by MarketBeat users. Likewise, 69.35% of users gave Aldeyra Therapeutics an outperform vote while only 63.60% of users gave Nature's Sunshine Products an outperform vote. CompanyUnderperformOutperformNature's Sunshine ProductsOutperform Votes16663.60% Underperform Votes9536.40% Aldeyra TherapeuticsOutperform Votes48269.35% Underperform Votes21330.65% Is NATR or ALDX more profitable? Nature's Sunshine Products has a net margin of 3.81% compared to Aldeyra Therapeutics' net margin of 0.00%. Nature's Sunshine Products' return on equity of 11.08% beat Aldeyra Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Nature's Sunshine Products3.81% 11.08% 7.23% Aldeyra Therapeutics N/A -43.01%-33.62% Do analysts prefer NATR or ALDX? Nature's Sunshine Products presently has a consensus price target of $19.00, indicating a potential upside of 18.75%. Aldeyra Therapeutics has a consensus price target of $10.00, indicating a potential upside of 110.08%. Given Aldeyra Therapeutics' higher probable upside, analysts plainly believe Aldeyra Therapeutics is more favorable than Nature's Sunshine Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nature's Sunshine Products 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Aldeyra Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryNature's Sunshine Products beats Aldeyra Therapeutics on 8 of the 14 factors compared between the two stocks. Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. Get Aldeyra Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALDX vs. The Competition Export to ExcelMetricAldeyra TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$294.18M$6.48B$5.06B$8.89BDividend YieldN/A8.11%4.97%4.06%P/E RatioN/A4.8389.0213.30Price / SalesN/A372.991,207.2881.01Price / CashN/A52.2739.1736.03Price / Book2.337.876.085.74Net Income-$37.54M$153.61M$119.07M$225.93M7 Day Performance11.48%-2.00%-1.84%-1.32%1 Month Performance-13.92%-7.47%-3.65%0.60%1 Year Performance95.08%31.80%31.62%26.23% Aldeyra Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALDXAldeyra Therapeutics1.6462 of 5 stars$4.76-3.6%$10.00+110.1%+78.9%$294.18MN/A0.0015Analyst RevisionNATRNature's Sunshine Products2.7901 of 5 stars$16.00+0.2%$19.00+18.8%-7.5%$295.68M$445.32M18.18814Positive NewsVSTMVerastem2.7372 of 5 stars$3.79-4.3%$12.50+229.8%-41.2%$176.25M$2.60M-1.1950Analyst DowngradeVRCAVerrica Pharmaceuticals4.5759 of 5 stars$0.89flat$9.60+981.8%-76.1%$40.58M$5.12M0.0040News CoverageVYNEVYNE Therapeutics2.55 of 5 stars$2.82+3.3%$6.88+143.8%-28.6%$40.27M$420,000.000.0030Analyst ForecastNXTCNextCure4.3842 of 5 stars$1.30-0.8%$4.00+207.7%+4.8%$36.69MN/A0.0090ANIPANI Pharmaceuticals4.4257 of 5 stars$55.10-1.1%$77.33+40.4%+7.4%$1.17B$486.82M0.00642Positive NewsMRVIMaravai LifeSciences4.7466 of 5 stars$4.82+4.1%$10.33+114.4%-2.2%$1.17B$288.95M0.00580Gap UpARDXArdelyx4.0013 of 5 stars$4.92+2.7%$10.42+111.7%+12.3%$1.17B$124.46M-16.40267Short Interest ↑AUPHAurinia Pharmaceuticals1.6758 of 5 stars$8.24+1.4%$10.00+21.4%-10.8%$1.16B$175.51M0.00300OPKOPKO Health4.458 of 5 stars$1.58-2.5%$2.75+74.1%+6.8%$1.11B$863.50M0.003,930 Related Companies and Tools Related Companies NATR Competitors VSTM Competitors VRCA Competitors VYNE Competitors NXTC Competitors ANIP Competitors MRVI Competitors ARDX Competitors AUPH Competitors OPK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ALDX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aldeyra Therapeutics, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aldeyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALDX Stock Alerts